2024-03-14
EQL's key product Mellozzan[®] has now gained marketing approval by the Health Authorities in the UK, where it is to be provided to patients by EQL's license partner Medice Arzneimittel Pütter GmbH...
2024-02-16
Regulatory
According to the resolution of the 2023 Annual General Meeting, the Nomination Committee shall be convened by the Chairman of the Board and consist of a representative of each of the three largest ...
2024-02-13
Regulatory
Growth and profitability despite large impact from the global antibiotics shortage and continued expansion of pipeline
2024-01-30
EQL Pharma AB (publ) will publish its quarterly report for the third quarter, 2023/24, on Tuesday, February 13[th], after stock markets closing.
At 10.00 (CET) 14[th] February, the company will gi...
2023-11-20
Every year, Dagens Industri appoints Sweden's fastest growing company to the so-called Gazelle company. It is an award to support and encourage Swedish entrepreneurs to grow.